Submit Article
Legal Analysis. Regulatory Intelligence. Jurisprudence.
Singapore

Biomedia Pharma Pte Ltd (formerly known as Malaysia Chemist Pte Ltd) v TAC Distribution Pte Ltd (trading as Trane Singapore) (Amcrotech Pte Ltd, third party) [2013] SGHC 2

In Biomedia Pharma Pte Ltd (formerly known as Malaysia Chemist Pte Ltd) v TAC Distribution Pte Ltd (trading as Trane Singapore) (Amcrotech Pte Ltd, third party), the High Court of the Republic of Singapore addressed issues of Contract — Remedies.

Case Details

  • Citation: [2013] SGHC 2
  • Case Title: Biomedia Pharma Pte Ltd (formerly known as Malaysia Chemist Pte Ltd) v TAC Distribution Pte Ltd (trading as Trane Singapore) (Amcrotech Pte Ltd, third party)
  • Court: High Court of the Republic of Singapore
  • Decision Date: 10 January 2013
  • Judge: Choo Han Teck J
  • Case Number: Suit No 143 of 2009 (assessment of damages)
  • Procedural Posture: Assessment of damages following an earlier liability judgment (judgment delivered on 8 November 2010)
  • Plaintiff/Applicant: Biomedia Pharma Pte Ltd (formerly known as Malaysia Chemist Pte Ltd)
  • Defendant/Respondent: TAC Distribution Pte Ltd (trading as Trane Singapore) (Amcrotech Pte Ltd, third party)
  • Third Party: Amcrotech Pte Ltd
  • Legal Area: Contract — Remedies (Damages)
  • Key Issue Type: Quantum of damages; refund of sums paid; general damages for inconvenience/trouble; causation and apportionment of business loss
  • Counsel for Plaintiff: Mansurhusain Akbar Hussein (Jacob Mansur & Pillai)
  • Counsel for Defendant: Niru Pillai (Global Law Alliance LLC)
  • Counsel for Third Party: Michael Chia Peng Chuang (Pereira & Tan LLC)
  • Hearing Dates (Damages Assessment): July 2012 (heard); verdict on 24 September 2012 (quantum); decision date 10 January 2013
  • Judgment Length: 2 pages; 549 words
  • Statutes Referenced: None stated in the provided extract
  • Cases Cited: [2013] SGHC 2 (no other authorities stated in the provided extract)

Summary

This High Court decision concerns the assessment of damages after the court had already found that TAC Distribution Pte Ltd (“TAC”) breached a contract to design and install a specialised air-conditioning system for Biomedia Pharma Pte Ltd (“Biomedia”). The earlier liability judgment, delivered on 8 November 2010, held TAC liable for breach of contract and dismissed TAC’s counterclaim and third-party action. The present judgment, delivered by Choo Han Teck J on 10 January 2013, focuses narrowly on quantum: how much money Biomedia should receive as damages for TAC’s failure to deliver a system that complied with the contractual requirements.

The court awarded Biomedia a total of $185,000. This comprised $135,000 as a reimbursement of the sum paid by Biomedia to TAC, and an additional $50,000 in general damages. The court accepted that TAC’s breach had a proven element of loss—namely, the payment made for the non-compliant system. It also recognised a further, less precisely quantifiable element of loss arising from the inconvenience and trouble Biomedia endured due to the breach. Importantly, the court did not assume that Biomedia’s business closure could be wholly attributed to TAC’s breach; instead, it treated the breach as a probable contributing factor and valued that contribution through a reasoned, discretionary assessment.

What Were the Facts of This Case?

Biomedia leased a factory building to operate its pharmaceutical business. The business required the factory to be used as a “dry laboratory”, which in turn depended on regulatory approval. TAC, a specialist in air-conditioning systems, contracted with Biomedia to design and install a specialised air-conditioning system for the factory. While TAC was responsible under the contract for the design and installation, the actual installation work was carried out by a third party, Amcrotech Pte Ltd.

After the system was installed, it became clear that TAC had failed to hand over a system that complied with the contract. This failure had regulatory consequences. Specifically, the Health Sciences Authority withheld the grant of a licence to Biomedia to use the factory as a dry laboratory. The withholding of the licence effectively undermined Biomedia’s ability to operate the intended pharmaceutical activities at the leased premises.

Biomedia sued TAC for breach of contract. In the liability phase, the High Court found in favour of Biomedia and ordered that damages be assessed. The defendant’s counterclaim and the third-party action were dismissed. The case then proceeded to a damages assessment hearing in July 2012, where the court considered the appropriate quantum for Biomedia’s claims.

During the assessment, the parties’ positions crystallised around the nature of the losses claimed. The payment of $135,000 by Biomedia to TAC was not disputed. However, TAC denied that there was a “failure of consideration” that would justify a refund. TAC’s argument was essentially that even if there was a contractual breach, Biomedia should not necessarily recover the amount paid as a reimbursement, particularly if the contract had not failed in its entirety in a way that would warrant restitutionary-style recovery. Biomedia also sought general damages, and the court had to determine whether and how to quantify the non-pecuniary or non-precisely measurable consequences of the breach.

The primary legal issue was the correct measure of damages for breach of contract in the circumstances of this case. Once liability had been established, the court had to decide what losses flowed from TAC’s breach and how those losses should be valued. This included determining whether the $135,000 paid by Biomedia should be reimbursed as damages, and whether the denial of “failure of consideration” had any bearing on the damages analysis.

A second issue concerned the relationship between the breach and Biomedia’s business outcomes. The court noted that the breach resulted in the Health Sciences Authority withholding the licence, and it was also clear that Biomedia’s business closure was at least probably connected to the breach. However, the court was careful not to treat the breach as the sole cause of closure. The legal question, therefore, was how to assess damages where causation is not perfectly linear and where the loss involves both proven and speculative components.

A third issue related to pleading and proof. The court indicated that some claims were special damages that had not been pleaded and therefore could not be awarded. This raised the procedural and substantive question of what categories of damages were properly before the court and which losses could be compensated given the pleadings and evidence.

How Did the Court Analyse the Issues?

Choo Han Teck J approached the assessment by separating the damages into components: (i) a proven pecuniary loss corresponding to the payment made for the non-compliant system, and (ii) a general or discretionary element representing inconvenience and trouble that could not be precisely measured. The court’s reasoning reflects a common damages methodology in contract cases: identify losses that are sufficiently proved and within the scope of what was pleaded, then quantify them, and finally address any remaining heads of loss that are real but not amenable to exact calculation through a reasonable award.

On the $135,000 reimbursement, the court held that the payment was not disputed and that it was “clear” TAC had failed to hand over a system complying with the contract. While TAC argued that Biomedia should not recover the refund because there was no “failure of consideration”, the court treated the breach as having caused a loss element that was clearly proved. In practical terms, the court accepted that Biomedia paid for a system that did not meet contractual requirements, and that the amount paid was recoverable as damages. This reasoning is consistent with the idea that contractual damages aim to place the claimant in the position it would have been in had the contract been properly performed, subject to proof and causation.

On the general damages, the court accepted that there was an element of loss that was not susceptible to precise assessment. The court identified the nature of this loss as the “inconvenience and trouble” endured by Biomedia due to the breach. This is a significant point for practitioners: even where the claimant’s losses include business disruption and regulatory consequences, not every downstream effect can be valued with mathematical precision. Where the evidence supports that the claimant suffered real non-pecuniary or operational disruption, the court may award general damages as a pragmatic measure.

The court then addressed causation and apportionment. It did not assume that Biomedia’s loss in business could be wholly attributed to TAC’s breach. Instead, the court treated the breach as a “probable contribution” to the closure of Biomedia’s business. The legal challenge is that business closure can have multiple causes, and damages must be tied to the breach with sufficient causal connection. The court’s solution was to take into account relevant contextual factors when valuing the contribution: the nature of the business, the consequence of the breach, the nature and size of the contract, and the nature of the breach. This reflects a structured, albeit discretionary, approach to quantifying damages where causation is probabilistic rather than exclusive.

In effect, the court used a two-step valuation: it awarded a specific amount for the proven payment loss ($135,000), and then added a further sum to reflect the general and business-disruption component ($50,000). The total award of $185,000 thus represented both a compensatory and a pragmatic assessment of damages, grounded in what was pleaded and proved, and tempered by the court’s caution about over-attribution of business loss.

Finally, the court dealt with the pleading constraint. It agreed with TAC’s counsel in part: special damages were not pleaded and therefore could not be awarded. This demonstrates the court’s adherence to procedural fairness and the requirement that claimants must plead the basis for special damages with sufficient specificity. However, the court distinguished between special damages that require precise proof and pleading, and the general element of loss that could be inferred from the proven breach and its consequences.

What Was the Outcome?

The court awarded Biomedia damages in the total sum of $185,000. The breakdown was $135,000 as reimbursement of the amount paid by Biomedia to TAC, and $50,000 in general damages for the inconvenience and trouble caused by TAC’s breach.

In practical terms, the decision confirms that where a contractor fails to deliver a system that complies with contractual specifications—particularly where compliance is tied to regulatory licensing—the claimant may recover the amount paid for the non-compliant performance and also obtain a general damages component to reflect operational disruption that cannot be precisely quantified. The court’s approach also indicates that claims for special damages must be properly pleaded, while general damages may be awarded where the breach and its consequences are established.

Why Does This Case Matter?

This case is useful for lawyers and law students because it illustrates a clear, pragmatic framework for assessing damages after liability has been established. The court’s reasoning shows how Singapore courts may treat a claimant’s payment for non-compliant contractual performance as a proven loss element, even where the defendant argues against restitutionary characterisation through the “failure of consideration” lens. While the decision is not framed as a restitution case, it demonstrates that damages assessment can effectively reimburse the claimant for the cost of defective or non-compliant performance where that cost is linked to the breach and is supported by the evidence.

Second, the decision highlights the role of general damages in contract disputes. Although contract damages are often thought of as compensating pecuniary loss, the court recognised that some consequences of breach—such as inconvenience and trouble—are real but not amenable to precise calculation. The court’s willingness to award a general sum underscores that general damages can be appropriate where the breach causes disruption that is demonstrably suffered but cannot be valued with exactitude.

Third, the case provides guidance on causation and apportionment in business-loss scenarios. The court did not award damages on the assumption that the breach wholly caused business closure. Instead, it treated the breach as a probable contributor and valued that contribution by considering the nature of the business, the consequence of the breach, and the contract’s characteristics. This approach is particularly relevant for practitioners dealing with complex factual matrices where multiple factors may have influenced the claimant’s commercial outcomes.

Finally, the decision reinforces procedural discipline: special damages must be pleaded and cannot be awarded if they are not properly set out. This is a practical reminder for litigators to ensure that heads of loss are correctly categorised and pleaded at the outset, and that evidence is aligned with the pleaded case.

Legislation Referenced

  • No specific statutes are referenced in the provided judgment extract.

Cases Cited

  • [2013] SGHC 2 (the present case; no other authorities are stated in the provided extract).

Source Documents

This article analyses [2013] SGHC 2 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the full judgment for the Court's complete reasoning.

Written by Sushant Shukla

More in

Legal Wires

Legal Wires

Stay ahead of the legal curve. Get expert analysis and regulatory updates natively delivered to your inbox.

Success! Please check your inbox and click the link to confirm your subscription.